原著論文
英文
-
Identification and management of interstitial lung disease associated with systemic sclerosis (SSc-ILD), rheumatoid arthritis (RA-ILD), and polymyositis/dermatomyositis (PM/DM-ILD): development of expert consensus-based clinical algorithms.
Kondoh Y, Bando M, Kawahito Y, Sato S, Suda T, Kuwana M.
Expert Rev Respir Med. 2024 Jul 15:1-10. doi: 10.1080/17476348.2024.2374910. Online ahead of print. -
Polyarteritis Nodosa（結節性多発動脈炎）
Aoki K, M.D., Kojima M, Ph.D.
New England Journal of Medicine 2024 May 9; 390: 1711. doi: 10.1056/NEJMicm 2309365 -
Successful treatment of lupus protein-losing enteropathy with belimumab: A case report
Kojima M, Hanaoka H, Aoki K, Matsushita H, Ito H, Yamada H.
Mod Rheumatol Case Rep. 2024 Jul 8;8(2):264-266. doi: 10.1093/mrcr/rxae010 -
Coexistence of anti-KS and anti-TIF1-𝛄 antibodies in clinically amyopathic dermatomyositis presenting with rapid progression of interstitial lung disease
Ota Y, Ohisa T, Ishii A , Sugiyama M, Kondo Y, Nishikawa A , Sasaki N , Yamada C, Sato S.
Mod Rheumatol Case Rep. 2024 Aug 1:rxae033. doi: 10.1093/mrcr/rxae03
学会発表
国際
-
ACR(アメリカリウマチ学会）
Efficacy and Safety of Nintedanib in Patients with Idiopathic Inflammatory Myopathy-related Interstitial Lung Disease
Aoki K, Shimura K, Ohisa T, Ishii A, Sugiyama M, Ota Y, Nishikawa A, Sasaki N, Yamada C, Sato S.
American College of Rheumatology Convergence 2024.2024.11.
